Nanostring Tech (NSTG)
MONEY FLOW INDEX
Trading: HOLD @ $20.84
Signal Strength: MEDIUM
Nanostring Tech (NASDAQ:NSTG) current trading has maintained the money flow index oversold status and signalled the continuation of the bullish trading conditions. Currently, the MFI is 84.78. The bullish signal has been active for 0 days. During the quarter, the lowest MFI value was 0.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Money Flow Index (MFI) is a volume-based indicator it could be used in technical analysis to measure the strength of money flow in and out of a security index and market. The principle of MFI calculation is a comparison of positive money flow to negative money flow. MFI is also known as volume-weighted RSI. MFI starts with the typical price for each period. The same as RSI the MFI scale is between 0 and 100.
Calculation: Money Flow Index (MFI):
1) Typical Price = (High + Low + Close)/3;
2) Raw Money Flow = Typical Price x Volume;
3) Money Flow Ratio = (14-period Positive Money Flow)/(14-period Negative Money Flow);
4) Money Flow Index = 100 - 100/(1 + Money Flow Ratio)
PROFILE: Nanostring Tech (NSTG)
Stock Exchange: NASDAQ
Company: Nanostring Tech
Ticker Codes: | NSTG | NASDAQ:NSTG |
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer and 360 gene expression, protein immune profiling, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, nCounter Vantage 3D, miRNA expression, cancer copy number variation, and other gene expression panels. Further, the company offers nCounter-based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; and Astellas Pharma, Inc., as well as the Cancer Therapy Evaluation Program of the National Cancer Institute. The company was founded in 2003 and is headquartered in Seattle, Washington.
Money Flow IndexDownload
|SGYP Synergy Pharma||0.29||19.2||14,776,164||56.53||NEUTRAL|
|AGEN Agenus Inc||3.73||16.9||6,440,824||24.71||NEUTRAL|
|ELGX Endologix Inc||0.87||14.2||1,877,810||51.76||NEUTRAL|
|SBNY Signature Bank||121.32||7.9||1,561,275||72.5||NEUTRAL|
|CLDX Celldex Therapeutics||0.29||7.4||2,744,927||66.88||NEUTRAL|
|ACHN Achillion Pharmaceuticals||2.3||7||2,440,655||41.61||NEUTRAL|
|ZIOP Ziopharm Oncology||2.48||6.9||1,828,565||56.19||NEUTRAL|
|MRTN Marten Transport||18.86||6.6||477,990||67.91||NEUTRAL|
|NYNY Empire Resorts Inc||14.31||6.4||29,432||76.91||NEUTRAL|
|INSM Insmed Inc||24.69||6.3||1,493,729||38.34||NEUTRAL|